GUANGDONG BIOLIGHT MEDITECH CO., LTD. Guangdong Biolight Meditech Co., Ltd. Stock
Equities
300246
CNE1000015Q4
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.21 CNY | -2.05% |
|
-13.27% | -39.71% |
| Sales 2021 | 1.09B 151M | Sales 2022 | 1.18B 163M | Capitalization | 2.87B 396M |
|---|---|---|---|---|---|
| Net income 2021 | 63M 8.7M | Net income 2022 | 22M 3.04M | EV / Sales 2021 | 2.94 x |
| Net Debt 2021 | 19.97M 2.76M | Net cash position 2022 | 352M 48.66M | EV / Sales 2022 | 2.13 x |
| P/E ratio 2021 |
50
x | P/E ratio 2022 |
128
x | Employees | 1,378 |
| Yield 2021 |
0.92% | Yield 2022 |
1.23% | Free-Float | 70.29% |
More Fundamentals
* Assessed data
More news
| 1 day | -2.05% | ||
| 1 week | -13.27% | ||
| Current month | -17.75% | ||
| 1 month | -19.97% | ||
| 3 months | -34.22% | ||
| 6 months | -45.24% | ||
| Current year | -39.71% |
1 week
5.96
7.13
1 month
5.968.07
Current year
5.0710.57
1 year
5.0712.79
3 years
5.0715.75
5 years
5.0733.11
10 years
5.0748.53
| Managers | Title | Age | Since |
|---|---|---|---|
Jin Yuan Yan
CEO | Chief Executive Officer | 61 | 08-01-19 |
Wei Wei Xu
DFI | Director of Finance/CFO | 49 | 22-12-25 |
Jin Liang
CTO | Chief Tech/Sci/R&D Officer | 50 | 13-12-29 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jun Dong Xue
BRD | Director/Board Member | 52 | 21-07-04 |
Jian Chen
BRD | Director/Board Member | 56 | 23-09-20 |
Jin Yuan Yan
CEO | Chief Executive Officer | 61 | 08-01-19 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-18 | 6.21 | -2.05% | 3 960 694 |
| 24-04-18 | 6.34 | -3.06% | 5,744,050 |
| 24-04-17 | 6.54 | +9.00% | 6,907,921 |
| 24-04-16 | 6 | -8.12% | 7,700,340 |
| 24-04-15 | 6.53 | -8.03% | 6,735,852 |
End-of-day quote Shenzhen S.E., April 18, 2024
More quotes
GUANGDONG BIOLIGHT MEDITECH CO., LTD. is a China-based company principally engaged in the research, development, production and sales of medical monitoring equipment, hemodialysis products and ancillary products. Its medical monitoring equipment includes monitoring equipment, electrocardiograph, pulse oximeters and central monitoring systems. Its hemodialysis products include hemodialysis machines, hemodialyzers, hemodialysis powders/dialysates and perfusion machines. The Company distributes its products in domestic and overseas markets.
Calendar
2024-04-24
- Q1 2024 Earnings Release
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -39.71% | 232M | |
| -2.53% | 183B | |
| -3.52% | 105B | |
| +5.33% | 51.77B | |
| +16.43% | 47.29B | |
| -1.73% | 40.2B | |
| +5.66% | 27.62B | |
| -2.01% | 25.51B | |
| +9.84% | 24.73B | |
| -1.87% | 24.52B |
- Stock Market
- Equities
- 300246 Stock
